• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

The Difference in All-Cause Mortality Between Allergic Bronchopulmonary Aspergillosis with and without Chronic Obstructive Pulmonary Disease
Source: Journal of Asthma and Allergy - December 28, 2022 Category: Allergy & Immunology Tags: Journal of Asthma and Allergy Source Type: research

Chronic rhinosinusitis is associated with non –cystic fibrosis bronchiectasis: A new clinical implication?
Bronchiectasis is a rare pulmonary disease characterized by aberrant mucociliary clearance, recurrent infections, mucus production, and mucosal damage leading to permanent dilatation of bronchi.1 Several conditions may coexist with non –cystic fibrosis bronchiectasis, such as chronic obstructive pulmonary disease (COPD), recurrent pneumonia, asthma, aspirin-exacerbated respiratory disease, allergic bronchopulmonary aspergillosis, immune deficiency, primary ciliary dyskinesia, alpha 1-antitrypsin deficiency, and obstructive sleep apnea (OSA).
Source: Journal of Allergy and Clinical Immunology - July 12, 2022 Category: Allergy & Immunology Authors: Jarkko M äntylä, Paula Kauppi, Sanna Toppila-Salmi Tags: Editorial Source Type: research

Disease Burden Among Patients With Multiple Overlapping Eosinophilic Diseases In The Real World Investigation Of Eosinophilic-Associated Disease Overlap (REVEAL) Study
The pathogenesis of multiple eosinophilic diseases (EDs) likely involves EID. Epidemiology and disease overlap among EDs are poorly understood. REVEAL is a retrospective claims study examining disease overlap among EDs, including allergic bronchopulmonary aspergillosis, atopic dermatitis, bullous pemphigoid, chronic spontaneous urticaria (CSU), asthma, COPD, chronic rhinosinusitis with nasal polyps, eosinophilic granulomatosis with polyangiitis, eosinophilic esophagitis (EoE), eosinophilic gastritis/gastroenteritis, and non-cystic fibrosis bronchiectasis.
Source: Journal of Allergy and Clinical Immunology - February 1, 2022 Category: Allergy & Immunology Authors: Justin Kwiatek, Anamaria Brailean, Danuta Kielar, Rohit Katial, Xia Wang, Xiao Xu, Sharon MacLachlan, Yong Jin Kim, Michael Stokes, Heide Stirnadel Farrant Source Type: research

Allergic bronchopulmonary aspergillosis complicating Swyer-James-Macleod's syndrome: case report and review of literature.
Authors: Sehgal IS, Dhooria S, Behera D, Agarwal R Abstract Allergic bronchopulmonary aspergillosis (ABPA) is a pulmonary disorder that results from immune responses mounted against antigens of Aspergillus fumigatus, resulting in non-specific respiratory symptoms and structural lung damage. Classically defined in individuals suffering from bronchial asthma and cystic fibrosis, ABPA has recently been described in other lung diseases including COPD, pulmonary tuberculosis, idiopathic bronchiectasis and others. Herein, we report the first case of ABPA complicating Swyer-James-Macleod's syndrome that was successfully t...
Source: European Annals of Allergy and Clinical Immunology - September 15, 2018 Category: Allergy & Immunology Tags: Eur Ann Allergy Clin Immunol Source Type: research

Allergic bronchopulmonary aspergillosis complicating COPD is associated with a higher exacerbation rate and a distinct pattern on chest CT scan compared to COPD
Recent data support that patients with COPD can experienced associated asthma in an overlap syndrome. This raise hypothesis of specific complications in these patients as allergic broncho-pulmonary aspergillosis (ABPA), usually seen in asthma patients, exhibiting potential specific features when associated to COPD. We compiled 16 cases of ABPA (Patterson criteria) diagnosed in COPD patients (GOLD criteria,Tabaco > 10 PY) in a monocentrique retrospective study, then compared to 16 COPD matched patients on age and FEV1, with similar overall follow up (7.8 years). ABPA-COPD group age was 61.1 years, FEV1 was 36% (1127mL), ...
Source: European Respiratory Journal - November 7, 2016 Category: Respiratory Medicine Authors: Maignant, A., Mellot, F., Haudebourg, L., Neveu, H., Rivaud, E., Catherinot, E., Bron, C., Salvator, H., Chabrol, A., Anitei, O., Trebbia, G., Devaquet, J., Cerf, C., Couderc, L.-J., Tcherakian, C. Tags: 5.3 Allergy and Immunology Source Type: research

Allergic bronchopulmonary aspergillosis complicating Swyer-James-Macleod's syndrome: case report and review of literature.
Authors: Sehgal IS, Dhooria S, Behera D, Agarwal R Abstract Allergic bronchopulmonary aspergillosis (ABPA) is a pulmonary disorder that results from immune responses mounted against antigens of Aspergillus fumigatus, resulting in non-specific respiratory symptoms and structural lung damage. Classically defined in individuals suffering from bronchial asthma and cystic fibrosis, ABPA has recently been described in other lung diseases including COPD, pulmonary tuberculosis, idiopathic bronchiectasis and others. Herein, we report the first case of ABPA complicating Swyer-James-Macleod's syndrome that was successfully t...
Source: European Annals of Allergy and Clinical Immunology - May 8, 2016 Category: Allergy & Immunology Tags: Eur Ann Allergy Clin Immunol Source Type: research

XXIV World Allergy Congress 2015
Table of Contents A1 Pirfenidone inhibits TGF-b1-induced extracellular matrix production in nasal polyp-derived fibroblasts Jae-Min Shin, Heung-Man Lee, Il-Ho Park A2 The efficacy of a 2-week course of oral steroid in the treatment of chronic spontaneous urticaria refractory to antihistamines Hyun-Sun Yoon, Gyeong Yul Park A3 The altered distribution of follicular t helper cells may predict a more pronounced clinical course of primary sjögren’s syndrome Margit Zeher A4 Betamethasone suppresses Th2 cell development induced by langerhans cell like dendr...
Source: World Allergy Organization Journal - April 18, 2016 Category: Allergy & Immunology Source Type: research

Aspergillus skin hypersensitivity in patients of COPD
This study is just a step forwards to explore this possibility and differentiate patients of COPD with element of aspergillus skin hypersensitivity so that they can be treated in a better way.
Source: European Respiratory Journal - December 23, 2014 Category: Respiratory Medicine Authors: Chopra, V., Mrigpuri, P., Mascerehnas, D. G. Tags: 5.3 Allergy and Immunology Source Type: research

The prevalence of increased serum IgE and Aspergillus sensitization in patients with COPD and their association with symptoms and lung function
Background: Allergy and Aspergillus hypersensitivity (AH) were shown to be associated with severe symptoms or worse lung function in COPD patients. The prevalence of elevated total IgE (T-IgE) and its association with clinical symptoms and lung function in COPD have not been studied. The prevalence of AH and its correlation with clinical characteristics in a COPD cohort of larger sample size is also lacking. Methods: 273 patients with COPD were evaluated by respiratory symptoms, blood test, chest HRCT, lung function, serum detection of T-IgE and Aspergillus specific IgE. Patients with T-IgE???1000KU/L were further investig...
Source: Respiratory Research - October 29, 2014 Category: Respiratory Medicine Authors: Jianmin JinXiaofang LiuYongchang Sun Source Type: research

Advances in environmental and occupational disorders in 2013
In this review of articles published in the Journal in 2013, we report on the significant advances in environmental and occupational disorders. Research advances have led to the identification and defined the structure and function of several major allergens. A meta-analysis confirmed the importance of mold exposure in patients with allergic rhinitis, and a new immunologic classification of aspergillosis emerged. Insights into the role of diesel exhaust particles in patients with severe asthma were clarified. Improvements in stinging insect allergy diagnostics were reported. Genetic, immunologic, and biomarker studies adv...
Source: Journal of Allergy and Clinical Immunology - April 28, 2014 Category: Allergy & Immunology Authors: David B. Peden, Robert K. Bush Tags: Advances in allergy, asthma, and immunology series 2014 Source Type: research